PMC:7105881 / 75-2134
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
38 | 6-19 | Species | denotes | coronaviruses | Tax:11118 |
39 | 21-25 | Species | denotes | CoVs | Tax:11118 |
40 | 51-57 | Species | denotes | humans | Tax:9606 |
41 | 104-108 | Species | denotes | CoVs | Tax:11118 |
42 | 120-165 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
43 | 167-175 | Species | denotes | SARS-CoV | Tax:694009 |
44 | 178-233 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
45 | 329-335 | Species | denotes | humans | Tax:9606 |
46 | 411-417 | Species | denotes | humans | Tax:9606 |
47 | 521-527 | Species | denotes | humans | Tax:9606 |
48 | 617-626 | Species | denotes | 2019-nCoV | Tax:2697049 |
49 | 718-724 | Species | denotes | people | Tax:9606 |
50 | 768-776 | Species | denotes | SARS-CoV | Tax:694009 |
51 | 781-789 | Species | denotes | MERS-CoV | Tax:1335626 |
52 | 913-918 | Species | denotes | human | Tax:9606 |
53 | 971-980 | Species | denotes | 2019-nCoV | Tax:2697049 |
54 | 1040-1047 | Species | denotes | new CoV | Tax:2697049 |
55 | 1146-1154 | Species | denotes | SARS-CoV | Tax:694009 |
56 | 1159-1167 | Species | denotes | MERS-CoV | Tax:1335626 |
57 | 1211-1217 | Species | denotes | humans | Tax:9606 |
58 | 1308-1313 | Species | denotes | human | Tax:9606 |
59 | 1314-1318 | Species | denotes | CoVs | Tax:11118 |
60 | 1381-1389 | Species | denotes | SARS-CoV | Tax:694009 |
61 | 1394-1402 | Species | denotes | MERS-CoV | Tax:1335626 |
62 | 1484-1489 | Species | denotes | human | Tax:9606 |
63 | 1490-1494 | Species | denotes | CoVs | Tax:11118 |
64 | 1851-1860 | Species | denotes | 2019-nCoV | Tax:2697049 |
65 | 1876-1880 | Species | denotes | CoVs | Tax:11118 |
66 | 258-261 | Species | denotes | CoV | Tax:11118 |
67 | 263-272 | Species | denotes | 2019-nCoV | Tax:2697049 |
68 | 315-325 | Disease | denotes | infections | MESH:D007239 |
69 | 389-407 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
70 | 504-517 | Disease | denotes | CoV infection | MESH:D018352 |
71 | 794-802 | Disease | denotes | zoonotic | MESH:D015047 |
72 | 919-929 | Disease | denotes | infections | MESH:D007239 |
73 | 1132-1142 | Disease | denotes | infections | MESH:D007239 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 1287-1295 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T2 | 1572-1579 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 1622-1629 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T4 | 1662-1670 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 120-153 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 167-175 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 315-328 | Disease | denotes | infections in | http://purl.obolibrary.org/obo/MONDO_0005550 |
T4 | 389-407 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 398-407 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 508-517 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T7 | 768-776 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 919-929 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 1132-1142 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 1146-1154 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 1381-1389 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 51-57 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T3 | 239-240 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 329-335 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T5 | 411-417 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T6 | 521-527 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T7 | 803-810 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T8 | 818-822 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bats |
T9 | 913-918 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T10 | 1082-1083 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T11 | 1182-1185 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T12 | 1211-1217 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T13 | 1308-1313 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T14 | 1484-1489 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T15 | 1971-1978 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Viruses |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1287-1295 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T2 | 1572-1579 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 1622-1629 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T4 | 1662-1670 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 308-325 | Phenotype | denotes | severe infections | http://purl.obolibrary.org/obo/HP_0032169 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-65 | Sentence | denotes | Seven coronaviruses (CoVs) have been isolated from humans so far. |
T4 | 66-388 | Sentence | denotes | Among them, three emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and a newly identified CoV (2019-nCoV), once caused or continue to cause severe infections in humans, posing significant threats to global public health. |
T5 | 389-616 | Sentence | denotes | SARS-CoV infection in humans (with about 10% case fatality rate) was first reported from China in 2002, while MERS-CoV infection in humans (with about 34.4% case fatality rate) was first reported from Saudi Arabia in June 2012. |
T6 | 617-762 | Sentence | denotes | 2019-nCoV was first reported from China in December 2019, and is currently infecting more than 70000 people (with about 2.7% case fatality rate). |
T7 | 763-930 | Sentence | denotes | Both SARS-CoV and MERS-CoV are zoonotic viruses, using bats as their natural reservoirs, and then transmitting through intermediate hosts, leading to human infections. |
T8 | 931-1072 | Sentence | denotes | Nevertheless, the intermediate host for 2019-nCoV is still under investigation and the vaccines against this new CoV have not been available. |
T9 | 1073-1218 | Sentence | denotes | Although a variety of vaccines have been developed against infections of SARS-CoV and MERS-CoV, none of them has been approved for use in humans. |
T10 | 1219-1495 | Sentence | denotes | In this review, we have described the structure and function of key proteins of emerging human CoVs, overviewed the current vaccine types to be developed against SARS-CoV and MERS-CoV, and summarized recent advances in subunit vaccines against these two pathogenic human CoVs. |
T11 | 1496-1752 | Sentence | denotes | These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potential factors affecting these subunit vaccines are also illustrated. |
T12 | 1753-1905 | Sentence | denotes | Overall, this review will be helpful for rapid design and development of vaccines against the new 2019-nCoV and any future CoVs with pandemic potential. |
T13 | 1906-1979 | Sentence | denotes | This review was written for the topic of Antivirals for Emerging Viruses: |
T14 | 1980-2059 | Sentence | denotes | Vaccines and Therapeutics in the Virology section of Frontiers in Microbiology. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 6-19 | NCBITaxon:11118 | denotes | coronaviruses |
T4 | 51-57 | NCBITaxon:9606 | denotes | humans |
T5 | 120-132 | SP_10 | denotes | severe acute |
T6 | 133-144 | SP_10;UBERON:0001004 | denotes | respiratory |
T7 | 145-165 | SP_10 | denotes | syndrome coronavirus |
T8 | 167-175 | SP_10 | denotes | SARS-CoV |
T9 | 178-189 | SP_9 | denotes | Middle East |
T10 | 190-201 | SP_9;UBERON:0001004 | denotes | respiratory |
T11 | 202-222 | SP_9 | denotes | syndrome coronavirus |
T12 | 224-232 | SP_9 | denotes | MERS-CoV |
T13 | 263-272 | SP_7 | denotes | 2019-nCoV |
T14 | 329-335 | NCBITaxon:9606 | denotes | humans |
T15 | 389-397 | SP_10 | denotes | SARS-CoV |
T16 | 411-417 | NCBITaxon:9606 | denotes | humans |
T17 | 499-507 | SP_9 | denotes | MERS-CoV |
T18 | 521-527 | NCBITaxon:9606 | denotes | humans |
T19 | 617-626 | SP_7 | denotes | 2019-nCoV |
T20 | 718-724 | NCBITaxon:9606 | denotes | people |
T21 | 768-776 | SP_10 | denotes | SARS-CoV |
T22 | 781-789 | SP_9 | denotes | MERS-CoV |
T23 | 803-810 | NCBITaxon:10239 | denotes | viruses |
T24 | 818-822 | SP_2;NCBITaxon:6960 | denotes | bats |
T25 | 913-918 | SP_6;NCBITaxon:9606 | denotes | human |
T26 | 971-980 | SP_7 | denotes | 2019-nCoV |
T27 | 1146-1154 | SP_10 | denotes | SARS-CoV |
T28 | 1159-1167 | SP_9 | denotes | MERS-CoV |
T29 | 1211-1217 | NCBITaxon:9606 | denotes | humans |
T30 | 1308-1313 | SP_6;NCBITaxon:9606 | denotes | human |
T31 | 1381-1389 | SP_10 | denotes | SARS-CoV |
T32 | 1394-1402 | SP_9 | denotes | MERS-CoV |
T33 | 1484-1489 | SP_6;NCBITaxon:9606 | denotes | human |
T34 | 1598-1604 | SO:0000417 | denotes | domain |
T35 | 1620-1629 | PG_1 | denotes | S protein |
T36 | 1851-1860 | SP_7 | denotes | 2019-nCoV |
T37 | 1971-1978 | NCBITaxon:10239 | denotes | Viruses |
T36628 | 6-19 | NCBITaxon:11118 | denotes | coronaviruses |
T19649 | 51-57 | NCBITaxon:9606 | denotes | humans |
T48275 | 120-132 | SP_10 | denotes | severe acute |
T53125 | 133-144 | SP_10;UBERON:0001004 | denotes | respiratory |
T63264 | 145-165 | SP_10 | denotes | syndrome coronavirus |
T47638 | 167-175 | SP_10 | denotes | SARS-CoV |
T81912 | 178-189 | SP_9 | denotes | Middle East |
T57284 | 190-201 | SP_9;UBERON:0001004 | denotes | respiratory |
T5316 | 202-222 | SP_9 | denotes | syndrome coronavirus |
T32993 | 224-232 | SP_9 | denotes | MERS-CoV |
T76811 | 263-272 | SP_7 | denotes | 2019-nCoV |
T78659 | 329-335 | NCBITaxon:9606 | denotes | humans |
T70251 | 389-397 | SP_10 | denotes | SARS-CoV |
T93319 | 411-417 | NCBITaxon:9606 | denotes | humans |
T55876 | 499-507 | SP_9 | denotes | MERS-CoV |
T73264 | 521-527 | NCBITaxon:9606 | denotes | humans |
T55869 | 617-626 | SP_7 | denotes | 2019-nCoV |
T67198 | 718-724 | NCBITaxon:9606 | denotes | people |
T95796 | 768-776 | SP_10 | denotes | SARS-CoV |
T29232 | 781-789 | SP_9 | denotes | MERS-CoV |
T37092 | 803-810 | NCBITaxon:10239 | denotes | viruses |
T43831 | 818-822 | SP_2;NCBITaxon:6960 | denotes | bats |
T95839 | 913-918 | SP_6;NCBITaxon:9606 | denotes | human |
T58242 | 971-980 | SP_7 | denotes | 2019-nCoV |
T89984 | 1146-1154 | SP_10 | denotes | SARS-CoV |
T56264 | 1159-1167 | SP_9 | denotes | MERS-CoV |
T11552 | 1211-1217 | NCBITaxon:9606 | denotes | humans |
T28582 | 1308-1313 | SP_6;NCBITaxon:9606 | denotes | human |
T48545 | 1381-1389 | SP_10 | denotes | SARS-CoV |
T62193 | 1394-1402 | SP_9 | denotes | MERS-CoV |
T56881 | 1484-1489 | SP_6;NCBITaxon:9606 | denotes | human |
T78790 | 1598-1604 | SO:0000417 | denotes | domain |
T16061 | 1620-1629 | PG_1 | denotes | S protein |
T29131 | 1851-1860 | SP_7 | denotes | 2019-nCoV |
T96476 | 1971-1978 | NCBITaxon:10239 | denotes | Viruses |